Issue #702 ![]() Jan 10, 2020 | Newsletter
The newsletter with chart analysis for stocks and stock indexes |
Stock Indexes Analysis/Evaluation
|
Nothing Decided Last Week, Making This Week an Indicative Week!
DOW Friday closing price - 31097
The indexes extended their rallies in a big way, having started the year by adding an additional 2+% to their year-end closing prices. In addition, all indexes closed on the highs of the week, suggesting further upside is to be seen this coming week. The main reason for the rally was the win in Georgia of both Democratic Senators that assures the new government that they can now give additional stimulus checks because they now control both the House and the Senate. The DOW has now appreciated 26% over the past 2 months.
The indexes are all overbought and in many ways over extended to the upside and more importantly, all the possible positive news is now factored into the prices and the only thing that can keep the indexes heading higher is momentum, which at this time is (and has been recently) a powerful force. By the same token, the traders will be facing one stark chart-history reality that in 4 of the past 7 years a correction has begun in the first or second week of the year when the indexes closed on new highs. Nonetheless, there was 1 year (of the last 7) where the indexes did not correct after closing on the highs of the year and that was in 2017, which was the year Trump won the election and a tax cut was expected to happen that year. In the other 2 years where a correction did not occur at the beginning of the year, the indexes had just finished a correction at the end of the year and were oversold (not overbought as they are now). As such, the probabilities favor some type of reversal week with the indexes following through to the upside at the beginning of the week (due to the momentum seen at the end of the week) but then turning down and closing red by the end of the week.
There is no resistance above on the charts where the bears can gather to mount a strong and combined/concerted attack to push the market down so it will all be about the rate of momentum to the upside that will be watched. Evidently, with the closes on the high of the week and no resistance above, the bulls have open air and if the bulls are so bullish on the new administration (not highly likely), then further upside will continue and a runaway-freight-trading scenario will occur. If the momentum wanes by the end of Tuesday or at the latest Wednesday, the probabilities will favor a round of profit taking that could cause the indexes to begin a correction by Friday. Keep in mind that there are no more possibly positive catalytic events scheduled until the following week when Biden assumes the presidency and even then, Biden has been open about what he plans to do and therefore it is not likely that anything will change immediately after he takes over, meaning the bulls will not have any new ammunition with which to stop a profit taking binge from occurring, at least not until some chart support levels of consequence are reached, and those are not anywhere close by (previous all-time highs are the closest support and are far away.
One additional factor that is starting this week on Friday and will continue for the following 3 weeks is the earnings quarter. Earnings is always a key fundamental factor in the market and for the past few years it has been mostly a positive to the market in general. Nonetheless, this quarter is of particular importance as it is being measured against what happened 1 year ago when the pandemic was still not a problem and yet many of the earnings reports are already anticipated to be as good or better than last year. This will make some comparisons easier to make and therefore decisions easier to make as well. For example, JMP reports on Friday and is expected to come out at $2.58 and last year in January it was at $2.57. On Tuesday of the following week, GS is expected to come out at $7.01 and a year ago it was $4.69, and yet NFLX, which comes out the following Wednesday and evidently has done much better this year because of the pandemic, is expected at $1.39 but last year was $1.30. Either way, the comparisons of year to year are going to allow traders to be a bit more aware on some stocks whether these new all-time high prices are supported or not.
As far as close by support is concerned, the indexes did generate a relatively big red day on Monday of last week and those lows (DOW at 30223, SPX at 3662, and NASDAQ at 12543) are now short-term pivotal support. Nonetheless, on a weekly closing basis, there is absolutely no support of consequence until the previous all-time high weekly closes are reached (DOW at 229398, SPX at 3508 and NASDAQ at 11695) and that means the DOW could correct as much as 5.5%, the SPX as much as 8.8% and the NAZ as much as 11.2%, if and when a correction does begin.
For this reason (possible start of a correction), this coming week is important. If no red close occurs next Friday, there will be no stopping the indexes from doing what they did in 2017, which was rally over 25% higher that year (by the end of the year) without a strong correction. I do not believe this will happen this year under a Biden administration that is likely to raise taxes (not cut them as in 2017). Then again and with the vaccines already being delivered, the economy could continue to generate growth all year. These are the fundamental questions that may begin to be answered this week, if and when a green or red weekly closes occurs next Friday.
I lean to the side of the bears and believe a correction will start this week but this is more about the fundamental picture than it is about charts. As such, I cannot give a probability assessment this week.
OIL broke out this week, having closed above the weekly close resistance at the $50 demilitarized zone. This was a positive statement that further upside up to the $55 demilitarized zone will be seen. Nonetheless, the resistance there is decent and not likely to be broken unless the indexes continue on their runaway-freight-train ride. The resistance in that area stood up for over 26 weeks back in early 2017 and did generate moves down to the $43 level during that period of time. The same scenario is likely to be seen on this occasion. By the same token and like in 2017, this scenario is more likely to be seen in a peaks and valleys format that in a straight line up and then down. It could take as long as 4-6 months to be fulfilled. Nonetheless, Oil did close on the high of the week and further upside above last week's high at 52.74 is expected to be seen this week and there is no resistance above until 54.50, meaning that is likely to be the objective this week. Support will now be found at the $50 demilitarized zone and then a bit stronger at 49.10, all based on daily closes. Probabilities favor the bulls.
DOLLAR I am going to mention the Dollar index this week given that it is important to Gold. The Dollar index got down to 89.22 this past week and there is strong and pivotal support on a weekly closing basis at 89.07 (88.56 on an intraweek basis). The index generated a positive reversal week, having made that 2+-year low and then closing green, suggesting further upside above last week's high at 90.38 will be seen this week. Back in January 2018, the index got down to this area and spent 12 weeks trading between 88.56 and 90.57 and it is possible the same thing will occur now, meaning that 90.57 should be resistance this week. If that is the case, the index should head back down and that would likely mean that Gold will go back up.
|
Stock Analysis/Evaluation
|
CHART Outlooks
Due to the fact the indexes rallied last week but the possibility of a correction still open and beginning this week, I am not yet ready to chase anything to the upside and also given that there are few resistance levels above in a multitude of stocks and there is no assurance that a correction is about to begin, I have no new buy or sell recommendations at this time. The 2 mentions from last week remains viable at the desired entry points mentioned. Those levels are still likely to be reached if a correction begins.
By the same token, if the action during the week clarifies the picture, I will offer mentions on the message board, be it sell mentions or buy mentions. If the indexes are to continue higher, I will consider chasing the stocks using last week's lows as new stop loss levels. Nonetheless, none of this will even begin to give a clearer picture until at least midweek, meaning that doing anything with these mentions on Monday or even Tuesday is not likely to happen.
As far as mentions for this week, 2 of the 3 mentions given the past two weeks are still viable and likely to reach the desired entry points this week. I am also including one new mention on an existing held stock, either to add positions or start a new one.
MRNA Friday Closing Price - 112.75
MRNA appreciated over 600% in price between May and December based on the anticipation of a Covid-19 vaccine being produced before the end of the year. That anticipation turned to fact a few weeks ago but it has become the classic case of "buy the anticipation and sell the fact" adage as the stock has dropped 43% in value over the past 4 weeks.
Though the drop seen in MRNA strongly suggests that the 178.50 high seen on December 1st is now a valid top that requires new positive fundamentals to be broken, the stock is still showing a lot of profit potential for this year with the vaccine that is now being distributed. This move down is likely to be an attempt to discover the minimum true value price of the stock and build a support base from which traders can buy with confidence. Such a level is likely to be the previous all-time high made in July of last year at 94.85. Then again, with the positives economics of the vaccine already proven, it is possible that buying interest will begin to appear as that previous high is neared, meaning that a drop down to that specific level might not occur.
The $100 level is a psychological support area that is likely to be reached but not necessarily broken, at least not below the $97 level, suggesting that purchases of some shares could begin with a drop below 100.00 and a full complement of shares-to-be-bought completed either on a drop down to 94.85 or when a support level has been built and buying has begun to be seen.
MRNA generated an inside week last week, meaning there was no clear decision made as to whether the stock has reached a defendable low and will start to rally or whether it was just a pause and the outlook mentioned last week will still be fulfilled. The stock did close in the middle of the week's trading range, also not showing any clear picture as to what it will do this week. The previous week, the stock closed near the low of the week and further downside below that week's low at 102.66 was expected to be seen. With the stock showing a minimum $20 trading range the past 6 weeks, the probabilities of a drop down to $100, or even down to 94.85 is a high probability for this week, especially considering that 118.94 is now a short term pivotal resistance. Simply stated, the probabilities are high this week that the stock will drop down to the desired entry point of the trade.
To the downside and on an intraweek basis, shows pivotal support at 88.61 that if broken, would suggest there are some fundamental problems with the company, which at this time are not publicly evident and therefore the support not likely to be broken. This means that a stop loss at 88.51 is a dependable stop loss to be used on a purchase. With this big drop, it is now strongly likely that a top to the upside at 178.50 is set for some time. Nonetheless, a rally back up to test the highs is likely to occur, suggesting that for the next 6 months the stock will be a trading stock rather than an investing stock. To the upside, there are only 2 minor-and-not-likely-to-stop-a-rally resistance levels above before any real resistance is found. There is resistance at 118.94 and then nothing until 147.26. The strong and indicative resistance is found at 163.75 that could be neared but not likely broken, meaning the stock is likely to trade between $100 and $160 for the next 4-6 months. All of these resistance levels are on the daily chart and not the weekly chart, meaning that on any indication that this correction is over, the buying interest is likely to be strong and immediate until the important resistance level is reached.
Purchases of MRNA below 100.00 and using a stop loss at 88.51 and having a $160 objective will offer a 5-1 risk/reward ratio.
My rating on the trade is a 4.25 (on a scale of 1-5 with 5 being the highest).
PFE Friday Closing Price - 37.13
PFE is another company like MRNA that has developed a vaccine for the virus but that has also suffered from the "buy the anticipation and sell the fact" adage, given that the stock has dropped 13.3% after the vaccine was approved by the FDA and has begun to be distributed. Nonetheless, PFE is a much more established company that produces many other medical products and therefore the chart action is more predictable, the support stronger, and the price action less, meaning less potential profit but less risk and less volatility. In simple words, a safer stock to trade.
One strong additional reason to choose PFE over MRNA (if you don't want to trade both) is that the stock made a new all-time high 2-years ago and before the pandemic, meaning that the bulls have a clear upside objective to shoot for (and break), whereas MRNA does not. Simply stated, there is a clear path for the traders to trade technically whereas not in the other stock and which offers additional profit potential.
PFE, like MRNA also generated an inside week last week, meaning there was no clear decision made as to whether the stock has reached a defendable low and will start to rally or whether it was just a pause and the outlook mentioned last week will still be fulfilled. Nonetheless, the stock did get down clearly into the desired entry point and did close in the upper half of the week's trading range, suggesting a slightly higher chance of having reached a viable low to this correction than not. If the stock does goes above last week's high at 37.53 this week, then a new entry point will be chosen when the stock goes back down to retest last week's low.
PFE does have one additional potential downside objective, being the 200-week MA, currently at 35.81, and it is even possible/probable that the 200-day MA, currently at 38.84, might be reached intraweek as well. One additional MA line that has been relatively dependable is the 100-week MA, currently at 36.25, meaning that there is a lot of support between 34.84 and 36.25 that the chart traders will use to enter a buy trade on the stock.
To the upside and on a weekly closing basis, PFE shows resistance at 36.98, at 38.40 and pivotal at 41.12. On an intraweek basis, those resistance levels are at 37.40, at 38.84 and at 43.02 respectively.
The benefits in 2021 of the vaccine the company has developed are likely to keep the stock in an uptrend or at least with a positive bias, meaning that a break of the 200-week MA at 35.81 is not likely to happen. With the stock having gotten down to 36.29 this past week and within $.38 cents of that support, buying interest will begin to appear this week.
PFE being an established company that depends on many other things not related to the Covid-19 vaccine, has potential to reach (and possibly break) the all-time high 44.05 made 2 years ago in December 2018. Nonetheless, even if only the vaccine benefits are in play, a retest of the recent high at 43.05 is likely to occur, meaning that at the very minimum, a rally back up to the 41.00 level is likely to be seen.
The stop loss on the trade will be at 34.65 and with an entry point around 36.00 and a minimum objective of $41, it means the risk is only $1.35 per share with a minimum profit potential of $5 per share, which is a 3.7-1 risk/reward factor. Purchasing PFE over MRNA offers more security but less profit potential and certainly less volatility.
My rating on the trade is 4.25 (on a scale of 1-5 with 5 being the highest).
|
Updates
|
Updates on Held Stocks |
Closed Trades, Open Positions and Stop Loss Changes |
AU generated a green weekly close above the 22.75 level, negating the previous failure signal against the bulls when it closed below the 22.75 level. Nonetheless, the stock did generate a spike rally at the beginning of the week but then turned down to close near the low of the week, suggesting further downside below last week's low at 22.72 will be seen this week. The spike rally and subsequent close near the low does suggest that for the time being the resumption of the uptrend is on hold and that the stock is likely to be trading sideways for a few weeks with likely a slight bullish bias. Nonetheless, last week's high at 25.75 is a new resistance level with a measure of strength given that the 200-day MA is currently at 26.01 and it was tested successfully, meaning the bulls have not yet been able to negate totally the short-term downtrend. There is some minor but likely short-term pivotal support at 22.31 that if broken will give the short-term edge back to the bears. If not broken, the bulls will have the short-term edge. Probabilities favor the bulls this week. AXP generated a new 10-month intraweek high but then fell back to close on Friday below the previous 10-month high weekly close at 125.04, meaning that the breakout was not convincing. The day of the breakout (Thursday) turned out to be a negative reversal day and that was not negated on Friday, meaning that the bulls continue with the edge but not in full control. The stock does not report earnings until the 26th but this week, C, JPM and WFC come out on Friday and those reports will give some clue as to how the financial industry is doing, meaning that next Friday could be indicative for the stock. For now, pivotal support is at 113.72 and short term pivotal resistance is at last week's high at 125.69, which if broken would suggest a rally to 126.64 would be seen. I don't believe either will be broken this week but I do believe the bias will slightly favor the bears. BTZI did not do anything indicative this past week (based on the daily and weekly closing charts) but the bulls were able to prevent the bears from making any statement (even a minor one), given that the stock was supposed to follow through to the downside this past week but did exactly the opposite, having gone above the previous week's high rather than below the previous week's low, as was expected. The stock closed on the high of the week and further upside above last week's high at .05 is expected to be seen this week. An important stock in the industry (CRON) did break out and as such, the probabilities favor the stock following suit. Pivotal resistance is found at .055 that if broken, the chart shows open air above until .088. Support remains at .035. Probabilities favor the bulls and also favor a breakout. CAT generated the biggest up week since June, having moved up this week a total $17.12 cents from low to high (an 8.7% rally). The stock once again, made a new all-time intraweek and weekly closing high and closed in the upper half of the week's trading range, suggesting further upside above last week's high at 197.39 will be seen this week. The company reports earnings on January 29th but the earnings are expected to be 45% lower than last year but the stock is trading 25% higher in price that when it reported earnings a year ago, which is certainly not a positive for further upside at this time. There is no previous established resistance above but the $200 level is a psychological resistance, meaning that it is not likely that level will be broken or if broken, broken by much. The stock has not built any support of consequence below and is strongly overbought and all of this scenario offered above, opens the door for a correction occurring (or beginning to occur) before the earnings report comes out. The previous all-time high weekly close is at 170.41 and I have to believe that level is likely to be tested "before" the earnings report comes out in 3 weeks. As such and based on Friday's close at 194.26, the risk factor for the bulls is about $24 per share and the profit potential is about $6 per shares, making it a 1-4 risk/reward ratio. The momentum is what is keeping this stock going forward but I do believe this momentum will stop this week, especially if the indexes start to reverse downward. I would be a shorter of the stock if the $200 level was reached. CNX generated a new 9-month intraweek high but a new 12-month weekly closing high and closed on the high of the week, suggesting further upside above last week's high at 12.39 will be seen this week. More importantly, the stock closed on Friday above the 200-week MA, currently at 11.50, which is a line that had not been broken to the upside for the past 2 years and only broken 3 times (for very short periods of time) during the last 6 years. Simply stated, this looks to be highly indicative of the bulls having a strong short term edge if not close to having full mid-term control. There is intraweek resistance at 14.19 that must be broken before full control is established but on a daily closing basis, resistance is found at 12.90, meaning that if the bulls are able to generate a confirmed daily close above that level, the 14.19 will not only be seen but likely broken. To the downside, there are 2 levels of support on a daily closing basis that must be watched (at 12.00 and at 11.50). Evidently, any daily close below 12.00 will negate this breakout on the daily chart but a close below 11.50 will also generate an additional break of support and weaken the hands of the bulls. By the same token, only a daily close below 10.26 would be seen as a true negative. The probabilities favor the bulls given that they have been working building support of consequence since July and that gives the traders confidence that support below is dependable. With this stock having made an all-time high at 116.42 in July 2008 and been in a downtrend all the time since, the probabilities now favor the bulls attempting to reach the 18.16/19.05 level where a break of that resistance would confirm the "long term" down trend has changed. That level is the objective of this breakout. Probabilities favor the bulls. CRON made a new 15-month intraweek and weekly closing high and this happened after a week when the stock had closed on the low of the week and was under short term bear control. The reason for the move was the Senate runoff elections in Georgia when the Democrats won control of the Senate, which in turn opened the door wide open for Biden/Harris to make Marijuana legal in the U.S. Using the chart, there is resistance at 9.59 (very minor), between 10.39 and 10.56 (minor to perhaps decent), and at 11.90 (decent). With the news and the now likelihood of Marijuana being made legal in the near future, there seems to be no reason for the bears to sell other than at levels of resistance. It must be remembered though, that Cannabis companies are having problems selling their products due to black market sellers than selling because of current restrictions, though certainly the ability to sell in all 50 States will alleviate those problems substantially. As such, this breakout seems to be real and supported but at this time still somewhat limited in scope as to how high the prices will go to in the short-to-mid term basis. One very viable objective to the upside that could be reached within the next 6-12 months is the 15.30 level which has proven to be a resistance of some consequence. Nonetheless, with the stock at $9, it still means the stock could appreciate as much as 66% in value before encountering any chart resistance of consequence. It also needs to be mentioned that the stock is now also showing a breakaway/runaway gap formation that offers an 11.60 objective. The runaway gap between 7.78 and 8.11 is now important support. The gap should not be closed. On a shorter term and on a daily closing basis, the stock should not negate the breakout, meaning a daily close below 8.85 by more than 10 points. Probabilities strongly favor the bulls. ENG continued the breakout in a strong manner, having broken and closed above another decent weekly close resistance at 3.84. The stock closed in the upper half of the week's trading range, suggesting further upside above last week's high at 5.44 will be seen. This is now the 3rd weekly close resistance level broken, in addition to the 11-year downtrend line. Nonetheless, the stock has reached a level of resistance of long term consequence with yet another decent weekly close resistance at 5.25 that is further strengthened by a previous low weekly close at 5.19, that was the low weekly close following the drop from the all-time weekly closing at 14.71 and from which the all-time high at 17.31 was made thereafter. On an intraweek basis, the stock could get up as high as 5.68 and perhaps even as high 6.47 but it seems unlikely that any further upside could be seen without a new support level getting built. The chart seems to suggest that the $4 level could be the next support level built, meaning the stock could get into a $4-$5 trading range for a few months after this rally is finished. I do plan to get out of all the rest of my positions this coming week, possibly around 5.68 but definitely above $6. FCEL continued the recent uptrend, having made a new 30-month intraweek high this past week. The stock closed near the high of the week and further upside above last week's high at 16.94 is expected to be seen this week. Nonetheless, the stock is now reaching a level of resistance between $18 and $30 that stopped all rallies for over 1 year 5 years ago and that is unlikely to be broken any time soon. The resistance is minor around the $18 level, becomes decent around $20 and then strong at $30. Though the $30 level could be reached at some point in the future, it is not likely to be reached in the next 9 months. As such, traders will start looking to take profits and trading the stock as soon as the $20 level is reached. The $10 level has now become an established support that won't likely be broken any more, or at least until the fundamental picture changes and if the stock can establish itself this week and next above the $16 level, that level will become minor to decent support. There is an open runaway gap between 18.48 and 19.44 that will likely be the target for closure this week. If the bulls fail to close the gap, a fall back to $16 or lower is likely to be seen. If closed, the breakaway gap at 22.92 will be targeted. I am not planning to follow this stock any more if I am lucky enough to have the stock get up and close both gaps and I liquidate the positions. This stock has been a major pain in my behind for many years and I had given up on ever getting anything back. If I get out at 23.00, I will still have lost over 70% of my initial investment in this stock and that is a good enough reason for not trading it any more. Having recovered among that 30% over 176% of the losses I had in this stock 18 months ago, makes this rally a miracle. FNV did not follow through to the downside this past week after having made a new 9-month intraweek low the week before and closing on the low of the week, suggesting this past week would bring new lows. Instead, the stock went above the previous week's high and closed green, suggesting the worst is over. All of this happening in spite of the fact that Gold dropped $135 in price this past week. The stock did close in the lower half of the week's trading range and further downside below last week's low at 125.53 is expected to be seen this week. Nonetheless, the previous week's low was 123.75 and if that low is not broken, a drop below last week's low would likely mean a needed/required retest of that low will have occurred, if and when the stock rallies above next week's high the following week. There is a mountain of intraweek support between 123.96 and 125.01 that is likely to hold up. On a daily closing basis, there is support at 128.24, at 125.84, and at 124.52. Any green daily close from here on out, especially if on an intraweek basis the stock goes below last week's low, will be a positive and suggest the worst of the correction is over and a resumption of the uptrend is to resume. The 200-day MA is currently at 137.89 and any daily close above that level would be a strong positive, especially since it would mean the double high on the daily closing chart at 136.52 will have been broken. Probabilities slightly favor the bulls this week. NEM generated a failure signal against the bears, having closed on Friday above the 60.47/60.50 level that has been a bone of contention since October. The stock did spike up this past week but did not break any resistance levels above and then fell back to close in the lower half of the week's trading range, suggesting further downside below last week's low at 61.66 will be seen this week. The spike intraweek high at 65.78 will now become the new pivotal resistance level. An intraweek drop back down to the $60 level is expected to be seen this week, in fact there is an open gap at 60.53 that is not supported by fundamentals or the price in Gold and as such, should be closed. Nonetheless, the stock broke above the 200-day MA, currently at 61.76, and that line should not be broken to the downside, at least not on a confirmed basis any more, unless Gold continues lower. Pivotal support is now found at 59.42, that is broken would give the bears back full control. Probabilities slightly favor the bulls but some weakness is expected to be seen early in the week. QQQ once again made a new all-time intraweek and weekly closing high and closed on the high of the week, suggesting further upside above last week's high at 319.39 will be seen this week. Nonetheless, the stock under performed its mother (the NASDAQ all week and was dragged up at the end of the week by the index, suggesting that there is now some reluctance to go higher up. The same situation as with the index applies to the stock as far as there being no resistance above but also no expectation of additional positive news that will support higher prices without some form of correction occurring first. Short-term pivotal support is found at 309.31. Probabilities favor the bears for a red weekly close next Friday. SRUTF once again stayed in the same trading range as has been seen now for the last 10 weeks in a row, having closed at .0379 on Friday, which is the same area that it has closed at for that period of time. The stock closed on the low of the week, suggesting further downside below last week's low at .37 will be seen this week. By the same token, the action seen in the stock this past week was disappointing given that most Cannabis stocks generated some type of breakout but SRUTF did not budge. There is intraweek support at .03 and pivotal at .025 and resistance is found at .049, at .0659 and long term pivotal at .080. A break above or below either of those two levels would be indicative. I have to say that the probabilities favor the bulls but given the lack of positive action this past week, it is likely more of the same as seen previously will occur. W generated a positive reversal week, having made a new 5+-month low and then rallying above the previous week's high closing above it and near the high of the week, suggesting further upside above last week's high at 268.67 will be seen this week. It must be mentioned that the stock did get down to the 200-day MA, currently at 226.80, with last week's low at 222.28, which was where the line was at last Monday. With nothing negative happening to the stock or the indexes, the rally was mostly chart oriented as the MA line has not been broken for 7 months. Though the positive reversal week is a short-term positive, no resistance levels of pivotal consequence were broken and the midterm downtrend remains intact with the line of the down channel being presently at 276.00, meaning that the bears remain with some measure of short-term control in a stock that by nature is very volatile. The stock does not report earnings until February 2 and as such, it is likely to move with the indexes. If the indexes start a correction this week, the stock is likely to head lower. In fact, having made a new multi-month low, the chances of at least retesting that low (if not making a new low) are high. For now, I will continue to hold on to the shorts until some resistance level of consequence is broken or a new support base for a rally is built.
|
1) ENG - Averaged long at 1.31 (3 mentions). No stop loss at present. Stock closed on Friday at 4.73. 2) BTZI - Averaged long at .215 (2 mentions). No stop loss at present. Stock closed on Friday at .0479. 3) CRON - Averaged long at 10.4275 (4 mentions). No stop loss at present. Stock closed on Friday at 9.06. 4) SRUTF - Purchased at .36. No stop loss at moment. Stock closed on Friday at .0379. 5) W - Averaged short at 86.61 (2 mentions). No stop loss at present. Stock closed on Friday at 258.38. 6) CAT - Averaged short at 109.616 (3 mentions). No stop loss at present. Stock closed on Friday at 194.26. 7) QQQ - Averaged short at 192.995 (2 mentions). No stop loss at present. Stock closed on Friday at 319.03. 8) AXP - Averged short at 93.953 (3 mentions). No stop loss at present. Stock closed on Friday at 121.78. 9) AU - Averaged long at 26.106 (6 mentions). No stop loss at present. Stock closed on Friday at 23.33. 10) NEM - Purchased at 62.79. Averaged long at 61.08 (6 mentions). No stop loss at present. Stock closed on Friday at 62.79. 11) CNX - Averaged long at 9.10 (2 mentions). No stop loss at present. Stock closed on Friday at 12.10. 12) FNV - Purchased at 126.83. Stop loss at 123.65. Stock closed on Friday at 128.30. 13) CAT - Shorted for a day trade at 185.57. Covered shorts at 183.70. Profit on the trade of $187 per 100 shares minus commissions. 14) CAT - Purchased for a day trade at 187.15. Liquidated at 196.48. Profit on the trade of $2799 per 100 shares (3 mentions) minus commissions. 15) ENG - Liquidated at 4.72. Purchased at an average price of 1.92. Profit on the trade of $840 per 100 shares minus commissions. 16) AXP - Purchased for a day trade at 121.00. Liquidated at 124.26. Profit of $978 per 100 shares (3 mentions) minus commissions.
Previous Newsletters
|
The opinions and commentaries by Mr. De Vito are not a recommendation to buy or sell, but rather
a charting guideline, based on his own knowledge and experience, regarding the stocks he is following or
that are brought to him by others. Mr. De Vito does not presently offer a track record of his trading experiences.
No inference of success and/or failure should be assumed. The
information enclosed above, regarding his background, length of trading, and experience, is correct
but is not meant to suggest, state, or infer any future success in trading, based on his opinions. The information herewith included should only be used by investors who are aware of the risk inherent in securities trading. Mr. De Vito accepts no liability whatsoever for any loss arising from any use of the information and/or comments he supplies. |
![]() |
|
|